09/18/2026
There’s an important piece of context missing from the first slide.
These weren’t simply foods mentioned in passing.
These were recommendations given to one of my young breast cancer patients to help protect her bone health while taking hormone blocking therapy.
Aromatase inhibitors such as letrozole and anastrazole profoundly reduce estrogen. Accelerated bone loss and increased fracture risk are well recognized consequences of treatment.
When my patient asked her medical oncologist what she could do to support her bones, she was specifically encouraged to eat Oreo McFlurrys and was given a “bioavailable calcium” handout that also included foods like 60 Goldfish crackers, calcium fortified orange juice, processed bread, and other highly processed calcium fortified foods.
And here’s where I think we need to have a much bigger conversation.
A food containing calcium does not automatically make it a food I would recommend for bone health, especially for a patient undergoing breast cancer treatment.
Bone health is not a single nutrient equation.
We should be talking about bone density and fracture risk assessment, adequate protein, mineral rich whole foods, vitamin D status, resistance and weight bearing exercise, metabolic health, and when clinically indicated, bone modifying therapies such as bisphosphonates.
We can do better than simply asking, “How many milligrams of calcium does this contain?”
We need to ask:
What is the quality of the food delivering it? What else is coming with it? And does this recommendation make sense in the context of the whole patient?
This is one of the reasons I practice integrative oncology. Supporting someone through cancer treatment means looking beyond the medication and beyond a single nutrient to understand the terrain we’re asking that patient to heal in.
99% of people may look at this list and see “calcium rich foods” and see nothing wrong with it.
If you’re part of the 1% who sees the bigger problem, comment below and tell me what you noticed first.
